02 Mar 2023
RACGP declines participation in pharmacy prescribing stakeholder group
The Australian Pharmacy Council is going ahead with the development of accreditation standards for pharmacist prescribing.
02 Mar 2023
Four in five believe ‘vexatious’ complaint made against them
A survey shows many GPs think they have been a victim of improper use of the system – but definitions remain a grey area, as does the overall impact.
02 Mar 2023
BCNA’s Director Policy, Advocacy and Support Services elected to international breast cancer body
As Australia’s leading voice for people affected by breast cancer, BCNA is proud its Director of Policy, Advocacy and Support Services, Vicki Durston, has been elected president of the General Assembly of the ABC Global Alliance.
02 Mar 2023
$26 million for research to improve the health of LGBTIQA+ communities
The Australian Government will invest $26 million in health and medical research to improve treatment and care for LGBTIQA+ people. Funding is from the Medical Research Future Fund (MRFF)
02 Mar 2023
$12.6 million for international clinical trials to support access to high-quality, evidence-based and effective health care
Researchers can apply for funding under the 2023 International Clinical Trial Collaborations grant opportunity. Funding is from the Medical Research Future Fund (MRFF).
02 Mar 2023
Tribunal orders registration cancellation of nurse who assaulted a patient
A tribunal has ordered the cancellation of a nurse’s registration following his conviction of aggravated assault of a patient in a psychiatric ward
02 Mar 2023
Murdoch COVID-19 testing clinic to close
With declining demand for PCR testing, the Murdoch COVID-19 testing clinic will close this week.
02 Mar 2023
Proposed approaches to AHPRA data strategy
The RACGP has submitted feedback on the health regulator’s strategy to inform its overall approach to how data is shared
02 Mar 2023
Update on effectiveness of monoclonal antibodies against COVID variants
The Therapeutic Goods Administration (TGA) is aware of concerns about decreased effectiveness of monoclonal antibodies (mAbs) against the COVID-19 caused by emerging SAR-COV-2 variants. Other agencies including the FDA, EMA and NIH are also aware and have updated their recommendations accordingly.
01 Mar 2023
Top responses to changing practice economics
SPONSORED: The GP Insights report shows practices are overcoming economic challenges by putting their staff and patient experience at the forefront.